Stockreport

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF Acquisition adds taletrectinib, a next-generation, potentially best-in-class ROS1 inhibitor with Breakthrough Therapy Designations currently completing two pivotal stud [Read more]